Evolent Health (EVH) Cash from Investing Activities (2015 - 2026)

Evolent Health's Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$6.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 51.07% year-over-year to -$6.4 million; the TTM figure through Mar 2026 stood at $6.5 million (up 109.74% YoY), while the FY2025 annual figure was -$233000.0, up 99.63% from the prior year.
• Cash from Investing Activities was -$6.4 million for Q1 2026 at Evolent Health, down from $82.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $82.2 million in Q4 2025 to a low of -$395.0 million in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$43.8 million across 5 years, with a median of -$9.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 14081.81% in 2022, then soared 512.21% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$4.5 million in 2022, then slumped by 35.82% to -$6.1 million in 2023, then slumped by 229.31% to -$19.9 million in 2024, then jumped by 512.21% to $82.2 million in 2025, then plunged by 107.8% to -$6.4 million in 2026.
• The last three Cash from Investing Activities figures came in at -$6.4 million (Q1 2026), $82.2 million (Q4 2025), and -$8.8 million (Q3 2025), per Business Quant data.